Abstract:Background. MicroRNAs (miRNAs) have been found in virtually all body fluids and used successfully as biomarkers for various diseases. Evidence indicates that miRNAs have important roles in IgA nephropathy (IgAN), a major cause of renal failure. In this study, we looked for differentially expressed miRNAs in IgAN and further evaluated the correlations between candidate miRNAs and the severity of IgAN.Methods. Microarray and RT-qRCR (real-time quantitative polymerase chain reaction) were sequentially used to screen and further verify miRNA expression profiles in urinary sediments of IgAN patients in two independent cohorts. The screening cohort consisted of 32 urine samples from18 patients with IgAN, 4 patients with MN (membranous nephropathy), 4 patients with MCD (minimal changes disease) and 6 healthy subjects; the validation cohort consisted of 102 IgAN patients, 41 MN patients, 27 MCD patients and 34 healthy subjects. The renal pathological lesions of patients with IgAN were evaluated according to Lee's grading system and Oxford classification.Results. At the screening phase, significance analysis of microarrays analysis showed that no miRNA was differentially expressed in the IgAN group compared to all control groups. But IgAN grade I-II and III subgroups (according to Lee's grading system) shared dysregulation of two miRNAs (miR-3613-3p and miR-4668-5p). At the validation phase, RT-qPCR results showed that urinary level of miR-3613-3p was significantly lower in IgAN than that in MN, MCD and healthy controls (0.47, 0.44 and 0.24 folds, respectively, all P < 0.01 by Mann-Whitney U test); urinary level of miR-4668-5p was also significantly lower in IgAN than that in healthy controls (0.49 fold, P < 0.01). Significant correlations were found between urinary levels of miR-3613-3p with 24-hour urinary protein excretion (Spearman r = 0.50, P = 0.034), eGFR (estimated glomerular filtration rate) (r = -0.48, P = 0.043) and Lee's grades (r = 0.57, P = 0.014). Similarly, miR-4668-5p was significantly correlated with eGFR (r = -0.50, P = 0.034) and Lee's grades (r = 0.57, P = 0.013). For segmental glomerulosclerosis according to Oxford classification, patients scored as S0 had significantly lower levels of urinary miR-3613-3p and miR-4668-5p than those scored as S1 (0.41 and 0.43 folds, respectively, all P < 0.05).Conclusions. The expression profile of miRNAs was significantly altered in urinary sediments from patients with IgAN. Urinary expression of miR-3613-3p was down-regulated in patients with IgAN. Moreover, urinary levels of both miR-3613-3p and miR-4668-5p were correlated with disease severity. Further studies are needed to explore the roles of miR-3613-3p and miR-4668-5p in the pathogenesis and progression of IgA nephropathy.

Profiling Of Serum And Urinary Micrornas In Children With Atopic Dermatitis

Identification of Candidate Genes in Atopic Dermatitis Based on Bioinformatic Methods

MicroRNA in Children with Asthma: Findings from Bronchoalveolar Lavage Fluid

MicroRNA-155 is a potential predictive tool for atopic dermatitis severity in children: A preliminary study

Identification of novel candidate genes and predicted miRNAs in atopic dermatitis patients by bioinformatic methods

MicroRNAs in Atopic Dermatitis: A Systematic Review

MicroRNA‑146a As a Potential Regulator Involved in the Pathogenesis of Atopic Dermatitis.

Characteristics of gut microbiota and serum metabolism in patients with atopic dermatitis

Systemic Inflammatory Proteomic Biomarkers in Atopic Dermatitis: Exploring Potential Indicators for Disease Severity

Potential Biomarkers of Atopic Dermatitis

The Association between Gut Microbiota and Serum Biomarkers in Children with Atopic Dermatitis

Identifying Immune Cell Infiltration and Constructing a Cerna Network to Explore Novel Diagnostic Biomarkers and Therapeutic Targets in Atopic Dermatitis

Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti‐IL‐4Rα therapy

Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab

Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome.

Exploring the Potential of IL-4 and IL-13 Plasma Levels as Biomarkers in Atopic Dermatitis

Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma.

Unique Gut Microbiome Signatures among Adult Patients with Moderate to Severe Atopic Dermatitis in Southern Chinese

Profiling and Initial Validation of Urinary Micrornas As Biomarkers in IgA Nephropathy

Genome-Wide Serum Microrna Expression Profiling Identifies Serum Biomarkers for Alzheimer'S Disease

MicroRNA profile as potential molecular signature for attention deficit hyperactivity disorder in children